Gasomia-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30mg and Rabeprazole 20mg, designed for the management of gastrointestinal disorders characterized by acid-related symptoms and motility disturbances. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric emptying and enhances upper gastrointestinal motility, thereby alleviating symptoms such as nausea, vomiting, bloating, and gastric discomfort. Rabeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. The synergistic action of these two agents in Gasomia-DSR Capsule offers symptomatic relief and promotes mucosal healing by reducing acid secretion and improving gastric motility. This combination is indicated for patients experiencing symptoms of acid reflux accompanied by delayed gastric emptying or dyspepsia. Gasomia-DSR should be used under medical supervision, with caution advised in patients with known hypersensitivity to either component, underlying cardiac conditions, or those on medications that may interact with domperidone or rabeprazole. Adherence to prescribed dosage and duration is essential to maximize therapeutic benefits and minimize adverse effects.